Background: Standardized chemotherapy used in cancer patients with severe kidney insufficiency is incon clusive.Although some pharmacokinetic studies of cyclophosphamide in kidney insufficiency patients have been reported,to the best of our knowledge,pharmacokinetic changes and safety a combination of cyclophosphamide and docetaxel as postoperative chemotherapy in a hemodialysis patient with early stage breast cancer is unclear to date.